4//SEC Filing
Eisner Mark 4
Accession 0001628280-25-007699
CIK 0001706431other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 3:39 PM ET
Size
272.7 KB
Accession
0001628280-25-007699
Insider Transaction Report
Form 4
Eisner Mark
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-22+80,000→ 80,000 totalExercise: $9.57Exp: 2035-02-21→ Common Stock (80,000 underlying) - Award
Common Stock
2025-02-22+40,000→ 115,000 total
Footnotes (2)
- [F1]Acquisition of restricted stock units pursuant to the Issuer's Equity Incentive Plan.
- [F2]25% of the shares subject to the stock option vest and become exercisable on February 22, 2026, and the remainder vest in 36 equal monthly installments thereafter.
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0001834161
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 3:39 PM ET
- Size
- 272.7 KB